|
Primary objective
|
Behavioural and psychological symptoms (BPSD)
|
Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change [33]
|
|
Secondary objective
|
Dimensions of BPSD
|
Neuropsychiatric Inventory (NPI) [35]
|
| | |
Cohen-Mansfield-Agitation-Inventory [36]
|
| |
Caregiver burden
|
NPI-caregiver-subscale [35]
|
| |
Application of antipsychotics
|
Chlorpromazine-equivalents [34]
|
| |
Application of benzodiazepine
|
Diazepam-equivalents [36]
|
| |
Motor behaviour
|
Body fixed motion sensor
|
| |
Saliva cortisol levels
|
Demeditec™ saliva kits [42]
|
| |
Neurotrophic factor levels
|
Brain-derived neurotrophic factor from blood-serum probes [44]
|
